HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [Kidney Int. Rep. 2021; https://doi.org/10.1016/j.ekir.2021.08.020].

Abstract
[This corrects the article DOI: 10.1016/j.ekir.2021.08.020.].
AuthorsFumihiko Koiwa, Shin Tokunaga, Shinji Asada, Yuichi Endo, Masafumi Fukagawa, Tadao Akizawa
JournalKidney international reports (Kidney Int Rep) Vol. 6 Issue 11 Pg. 2936-2937 (Nov 2021) ISSN: 2468-0249 [Electronic] United States
PMID34826317 (Publication Type: Published Erratum)
Copyright© 2021 International Society of Nephrology. Published by Elsevier Inc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: